← Browse by Condition
Medical Condition
systemic sclerosis
Total Trials
14
Recruiting Now
14
Trial Phases
Phase 1, Phase 2, Phase 2, EARLY_Phase 1
ClinicalMetric tracks all active clinical trials for systemic sclerosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — systemic sclerosis Clinical Trials
How many clinical trials are currently recruiting for systemic sclerosis?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for systemic sclerosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for systemic sclerosis?
systemic sclerosis research spans Phase 1 (7 trials), Phase 2 (5 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a systemic sclerosis clinical trial?
Eligibility criteria for systemic sclerosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 7
Phase 2 5
Phase 4 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT03211793 Phase 1, Phase 2
Recruiting
Enrollment
20 pts
Location
Netherlands
Sponsor
UMC Utrecht
NCT06947460 Phase 1, Phase 2
Recruiting
Enrollment
45 pts
Location
China
Sponsor
Beijing GoBroad Hospital
NCT07515638
Recruiting
Enrollment
500 pts
Location
France
Sponsor
University Hospital, Montpelli...
NCT04917705
Recruiting
Enrollment
55 pts
Location
France
Sponsor
University Hospital, Strasbour...
NCT05177380
Recruiting
Enrollment
60 pts
Location
France
Sponsor
University Hospital, Strasbour...
NCT04356755 Phase 2
Recruiting
Enrollment
32 pts
Location
France
Sponsor
University Hospital, Toulouse
NCT06328777 Phase 1, Phase 2
Recruiting
Enrollment
12 pts
Location
United States
Sponsor
Cabaletta Bio
NCT06462768
Recruiting
Enrollment
260 pts
Location
France
Sponsor
CHU de Reims
NCT06058091 Phase 1, Phase 2
Recruiting
Enrollment
81 pts
Location
China
Sponsor
Jiangsu Renocell Biotech Compa...
NCT07246096 EARLY_Phase 1
Recruiting
Enrollment
60 pts
Location
China
Sponsor
Changhai Hospital
NCT06775912 EARLY_Phase 1
Recruiting
Enrollment
18 pts
Location
China
Sponsor
Nanjing Bioheng Biotech Co., L...
NCT05989763
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
The University of Texas Health...
NCT06546540 Phase 4
Recruiting
Enrollment
20 pts
Location
China
Sponsor
Peking University Third Hospit...
NCT07085104 Phase 1
Recruiting
Enrollment
66 pts
Location
United States, Canad...
Sponsor
Allogene Therapeutics
Related Conditions
systemic lupus erythematosus (3) rheumatoid arthritis (2) digital ulcer (1) refractory lupus nephritis (1) primary sjogren 39 s syndrome combined with pulmonary hypertension (1) healthy adult volunteers (1) inflammatory myopathies (1) face (1) facial involvement (1) rehabilitation (1) scleroderma (1) other connective tissue disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology